{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-107449","form_type":"8-K","ticker":"SNSE","cik":"0001829802","company_name":"Sensei Biotherapeutics, Inc.","filed_at":"2023-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.959916+00:00","generated_at":"2026-06-16T22:42:48.940356+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Sensei Biotherapeutics updates corporate presentation for investor meetings","bullets":["Corporate presentation dated April 2023 furnished as Exhibit 99.1.","No specific clinical, financial, or operational updates disclosed in filing.","Presentation used for meetings with investors, analysts, and others.","Information furnished under Regulation FD, not deemed filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-107449","json":"https://secwatch.observer/filing/0001193125-23-107449.json","markdown":"https://secwatch.observer/filing/0001193125-23-107449.md","text":"https://secwatch.observer/filing/0001193125-23-107449.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1829802/000119312523107449/0001193125-23-107449-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1829802/000119312523107449/d453291d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T22:42:48.940356+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}